Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV
Authors
Keywords
-
Journal
IMMUNOLOGICAL INVESTIGATIONS
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2018-10-16
DOI
10.1080/08820139.2018.1527851
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Immune Epitope Database: How Data Are Entered and Retrieved
- (2017) Ward Fleri et al. Journal of Immunology Research
- The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment
- (2016) Amr Kandeel et al. LIVER INTERNATIONAL
- Three cases of congenital dysfibrinogenemia in unrelated Chinese families
- (2016) Meiling Luo et al. MEDICINE
- HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses
- (2016) Yuwei Zhang et al. Scientific Reports
- Toll-like receptor 3 gene polymorphisms are not associated with the risk of hepatitis B and hepatitis C virus infection
- (2015) Keyla Santos Guedes de Sá et al. Revista da Sociedade Brasileira de Medicina Tropical
- Innate and adaptive genetic pathways in HCV infection
- (2015) R. Buchanan et al. TISSUE ANTIGENS
- TNF-α Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism
- (2015) Jiyoung Lee et al. PLoS Pathogens
- Sex-specific association between X-linked Toll-like receptor 7 with the outcomes of hepatitis C virus infection
- (2014) Ming Yue et al. GENE
- Single Nucleotide Polymorphisms of Toll-Like Receptor 7 in Hepatitis C Virus Infection Patients from a High-Risk Chinese Population
- (2014) Xing-xin Xue et al. INFLAMMATION
- Natural history of hepatitis C
- (2014) Rachel H. Westbrook et al. JOURNAL OF HEPATOLOGY
- Intact Dendritic Cell Pathogen-Recognition Receptor Functions Associate with Chronic Hepatitis C Treatment-Induced Viral Clearance
- (2014) Ian Gaël Rodrigue-Gervais et al. PLoS One
- Single Nucleotide Polymorphisms of Toll-Like Receptor 7 and Toll-Like Receptor 9 in Hepatitis C Virus Infection Patients from Central China
- (2014) Xin-su Wei et al. YONSEI MEDICAL JOURNAL
- Hepatitis C Virus - Proteins, Diagnosis, Treatment and New Approaches for Vaccine Development
- (2013) Hossein Keyvani et al. Asian Pacific Journal of Cancer Prevention
- Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line
- (2013) Yizhong Wang et al. Innate Immunity
- Toll-like receptors in hepatitis C infection: Implications for pathogenesis and treatment
- (2013) Jessica Howell et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research--an update
- (2012) R. Peakall et al. BIOINFORMATICS
- Role of gut microbiota in liver diseases
- (2012) Yasuhiro Miyake et al. HEPATOLOGY RESEARCH
- Polymorphisms of Toll-like receptors and their pathways in viral hepatitis
- (2011) Rohit Sawhney et al. ANTIVIRAL THERAPY
- Role of Toll-like receptors in liver health and disease
- (2011) Ruth Broering et al. CLINICAL SCIENCE
- Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7
- (2009) Yi-Liang Zhang et al. JOURNAL OF HEPATOLOGY
- TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C
- (2009) Eva Askar et al. JOURNAL OF MEDICAL VIROLOGY
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started